The PI of this application is a physician-scientist with a career focus on developing improved care for patients with sickle cell disease (SCD). The acute chest syndrome (ACS) represents a serious, potentially fatal inflammatory lung injury syndrome occurring in patients with SCD. ACS shares many features of the inflammatory lung injury associated with acute lung injury and is the second most common cause of SCD hospitalization;is a major cause of acute and chronic SCD morbidity and mortality, is the leading cause of SCD ICU admission and premature death. There is increasing appreciation that ACS is an acute hypoxia-induced lung injury syndrome targeting the lung endothelium in response to multiple exogenous insults or triggers leading to pulmonary erythrocyte sequestration, an exaggerated inflammatory response, increased expression of adhesion molecules and impairment of pulmonary vascular function. In this highly translational proposal we will address the hypothesis that vascular-targeted genetic and genomic strategies for ACS will lead to better understanding of the pathobiology of ACS, generate novel ACS biomarkers in SCD patients and produce vascular-specific therapies for ameliorating this devastating health disparity. To address this hypothesis, in Specific Aim #1 we will identify novel single nucleotide polymorphisms that modulate ACS susceptibility and generate an ACS risk- conferring SNP panel.
Specific Aim #2 will refine and validate genome-wide, vascular-centric genomic of ACS risk in SCD patients.
In Specific Aim #3 we will interrogate the involvement of vascular permeability-regulatory pathway genes and proteins in murine ACS and ALI. Together, these highly translational approaches hold the promise to identify novel targets and biomarkers that may lead to better treatment options for patients with ACS.
This project will investigate the role of new genetic markers as risk factors for the development of acute chest syndrome, a major cause of death in patients with sickle cell disease. We will also investigate the role of genetic markers as a tool to identif patients with acute chest syndrome.
|Fraidenburg, Dustin R; Machado, Roberto F (2016) Pulmonary hypertension associated with thalassemia syndromes. Ann N Y Acad Sci 1368:127-39|
|Tran, Khiem A; Zhang, Xianming; Predescu, Dan et al. (2016) Endothelial Î²-Catenin Signaling Is Required for Maintaining Adult Blood-Brain Barrier Integrity and Central Nervous System Homeostasis. Circulation 133:177-86|
|Indik, Julia H; Nair, Vineet; Rafikov, Ruslan et al. (2016) Associations of Prolonged QTc in Sickle Cell Disease. PLoS One 11:e0164526|
|Duarte, Julio D; Desai, Ankit A; Sysol, Justin R et al. (2016) Genome-Wide Analysis Identifies IL-18 and FUCA2 as Novel Genes Associated with Diastolic Function in African Americans with Sickle Cell Disease. PLoS One 11:e0163013|
|Sysol, Justin R; Natarajan, Viswanathan; Machado, Roberto F (2016) PDGF induces SphK1 expression via Egr-1 to promote pulmonary artery smooth muscle cell proliferation. Am J Physiol Cell Physiol 310:C983-92|
|Hon, Yuen Yi; Lin, Elaina E; Tian, Xin et al. (2016) Increased consumption and vasodilatory effect of nitrite during exercise. Am J Physiol Lung Cell Mol Physiol 310:L354-64|
|Ebenezer, David L; Fu, Panfeng; Suryadevara, Vidyani et al. (2016) Epigenetic regulation of pro-inflammatory cytokine secretion by sphingosine 1-phosphate (S1P) in acute lung injury: Role of S1P lyase. Adv Biol Regul :|
|Han, Jin; Saraf, Santosh L; Zhang, Xu et al. (2016) Patterns of opioid use in sickle cell disease. Am J Hematol 91:1102-1106|
|Gordeuk, Victor R; Castro, Oswaldo L; Machado, Roberto F (2016) Pathophysiology and treatment of pulmonary hypertension in sickle cell disease. Blood 127:820-8|
|Singla, Sunit; Machado, Roberto F (2015) The imitation game in pulmonary arterial hypertension. Sex, bone morphogenetic protein receptor, and the estrogen paradox. Am J Respir Crit Care Med 191:612-3|
Showing the most recent 10 out of 25 publications